Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz, Jakub Debski, MD, Aleksandra K. Butrym, MD, PhD, Wojciech Legiec, Marek Hus, MD, PhD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan M Zaucha, Marcin Rymko, MD, Tigran Torosian, MD, Grzegorz Charlinski, Ewa Lech-Maranda, Artur J. Jurczyszyn, MD, PhD, Halina Urbanska-Rys, Agnieszka Druzd-Sitek, PhD, Kazimierz Kuliczkowski

Blood (2013) 122 (21): 3236.

https://doi.org/10.1182/blood.V122.21.3236.3236

Published: 2013

Journal Articles

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

Lidia Usnarska-Zubkiewicz, MD, Jakub Debski, MD, Aleksandra Butrym, MD, Wojciech Legiec, MD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan Maciej Zaucha, MD, Marcin Rymko, MD, Tigran Torosian, MD, Kazimierz Kuliczkowski

Blood (2011) 118 (21): 5125.

https://doi.org/10.1182/blood.V118.21.5125.5125

Published: 2011

Journal Articles

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Jerzy Holowiecki, Sebastian Grosicki, MD, Slawomira Kyrcz-Krzemien, Kazimierz Kuliczkowski, Marek Kielbinski, MD, Aleksander B. Skotnicki, Beata Jakubas, MD, Andrzej Hellmann, Tadeusz Robak, Marek J. Seweryn, MD, Beata Stella-Holowiecka, MD, Maria Sadus-Wojciechowska, MD

Blood (2007) 110 (11): 4375.

https://doi.org/10.1182/blood.V110.11.4375.4375

Published: 2007

Journal Articles

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

Jerzy Holowiecki Prof, Tomasz Czerw, MD, Jerzy Wojnar, MD, PhD, Malgorzata Krawczyk-Kulis, MD, PhD, Sebastian Grosicki, MD, Beata Stella-Holowiecka, MD, PhD, Slawomira Kyrcz-Krzemien Prof, Maria Sadus-Wojciechowska, MD, Sebastian Giebel, MD, Lucja Kachel, MD, Krzysztof Wozniczka, MD, Aleksandra Holowiecka-Goral, MD

Blood (2007) 110 (11): 2875.

https://doi.org/10.1182/blood.V110.11.2875.2875

Published: 2007

Journal Articles

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Jerzy Wojnar, MD, Sebastian Giebel, MD, Miroslaw Markiewicz, MD, Malgorzata Krawczyk-Kulis, MD, Iwona Wylezol, MD, Beata Stella-Holowiecka, MD, Tomasz Kruzel, MD, Jerzy Holowiecki

Blood (2006) 108 (11): 5245.

https://doi.org/10.1182/blood.V108.11.5245.5245

Published: 2006

Journal Articles

Occurrence and Treatment of Isolated Extramedullary Relapses after Allogeneic Hematopoietic Stem Cell Transplantation for Leukaemias: A Single Institute Experience with 442 Patients.

Dariusz Kata, MD, Jerzy Holowiecki, Jerzy Wojnar, MD, Beata Stella-Holowiecka, MD, Slawomira Krzemien, Krzysztof Wozniczka, MD, Grzegorz Helbig, MD

Blood (2006) 108 (11): 5337.

https://doi.org/10.1182/blood.V108.11.5337.5337

Published: 2006

Journal Articles

Improved Survival in Acute Myeloid Leukaemia Patients Aged over 40 Given Cladribine in Combination with Standard Remission Induction (DA 3+7) and Consolidation Treatment (HD AraC). Seven Year Follow-Up of Prospective, Cooperative PALG Study.

Jerzy Holowiecki, Sebastian Grosicki, MD, Andrzej Hellmann, Aleksander Skotnicki, Tadeusz Robak, Wieslaw W. Jedrzejczak, Lech Konopka, Kazimierz Kuliczkowski, Slawomira Kyrcz-Krzemien, Beata Stella-Holowiecka, MD

Blood (2006) 108 (11): 2003.

https://doi.org/10.1182/blood.V108.11.2003.2003

Published: 2006

Journal Articles

High Incidence of Ancestral HLA Haplotype 8.1 and Incomplete DH-JH Immunoglobulin Rearrangement in Persistent Polyclonal B-Cell Lymphocytosis.

Dariusz Wolowiec, MD, PhD, Miroslaw Majewski, MD, Jacek Nowak, MD, PhD, Beata Stella-Holowiecka, MD, PhD, Angelika Krawcewicz, MD, Renata Mika-Witkowska, Hanna Makuch-Lasica, Iwona Solarska, Olga Haus, MD, PhD, Ewa Duszenko, Kazimierz Kuliczkowski, MD, PhD, Krzysztof Warzocha, MD, PhD

Blood (2005) 106 (11): 3923.

https://doi.org/10.1182/blood.V106.11.3923.3923

Published: 2005

Journal Articles

Autologous Transplantation of Non-Cryopreserved Bone Marrow for the Treatment of High-Risk Adult Acute Lymphoblastic Leukemia in First Complete Remission.

Jerzy Holowiecki, Sebastian Giebel, MD, Malgorzata Krawczyk-Kulis, MD, Maria Sadus-Wojciechowska, MD, Lucja Kachel, MD, Jerzy Wojnar, MD, Beata Stella-Holowiecka, MD, Sebastian Grosicki, MD

Blood (2005) 106 (11): 5492.

https://doi.org/10.1182/blood.V106.11.5492.5492

Published: 2005

Journal Articles

Independent Prognostic Significance of Cytogenetics, Immunophenotype, Tumor Burden, and Age in Acute Myeloid Leukemia. Analysis of Patients Treated within PALG 1999 Prospective, Randomized Study.

Sebastian Grosicki, MD, Jerzy Holowiecki, Sebastian Giebel, MD, Olga Haus, MD, Beata Stella-Holowiecka, MD, Krystyna Jagoda, Aleksandra Bartkowska-Chrobok

Blood (2004) 104 (11): 4395.

https://doi.org/10.1182/blood.V104.11.4395.4395

Published: 2004

Journal Articles

CD52 and CD20 as Potential Targets for Anti-Leukemic Immunotherapy in Adult Acute Lymphoblastic Leukemia.

Krystyna Jagoda, PhD, Sebastian Giebel, MD, Beata Stella-Holowiecka, MD, Malgorzata Krawczyk-Kulis, MD, Jerzy Holowiecki

Blood (2004) 104 (11): 4403.

https://doi.org/10.1182/blood.V104.11.4403.4403

Published: 2004

Journal Articles

Lower Relapse Incidence after Non-Cryopreserved Autologous Bone Marrow Transplantation Compared to Peripheral Blood Stem Cell Transplantation for High-Risk Hodgkin’s Lymphoma.

Jerzy Holowiecki, Sebastian Giebel, MD, Malgorzata Krawczyk-Kulis, MD, Jerzy Wojnar, MD, Lucja Kachel, MD, Maria Sadus-Wojciechowska, MD, Beata Stella-Holowiecka, MD, Sebastian Grosicki, MD, Tomasz Czerw, MD

Blood (2004) 104 (11): 912.

https://doi.org/10.1182/blood.V104.11.912.912

Published: 2004

Journal Articles

Daunorubicin, Cytarabine and Fludarabine (DAF) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia. Phase II Study by the Polish Adult Leukemia Group (PALG).

Jerzy Holowiecki, Sebastian Grosicki, MD, Slawomira Krzemien, MD, Aleksander Skotnicki, Krzysztof Warzecha, Barbara Zdziarska, MD, Beata Stella-Holowiecka, MD, Malgorzata Krawczyk-Kulis, MD, Malgorzata Kopera, MD, Maria Wojciechowska, MD

Blood (2004) 104 (11): 4507.

https://doi.org/10.1182/blood.V104.11.4507.4507

Published: 2004

Journal Articles

Immunophenotyping to Detect Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia - Feasibility and Prognostic Significance.

Jerzy Holowiecki, Sebastian Giebel, MD, Krystyna Jagoda, PhD, Malgorzata Krawczyk-Kulis, MD, Beata Stella-Holowiecka, MD, Slawomira Kyrcz-Krzemien, MD, Monika Paluszewska, MD, Malgorzata Kopera, MD, Wlodzimierz Medrek, MD, Grazyna Bober, MD, Jacek Najda, MD

Blood (2004) 104 (11): 4489.

https://doi.org/10.1182/blood.V104.11.4489.4489

Published: 2004

NARROW

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

The Reduction of Leukemic Blasts in Bone Marrow Aspirate on Day 6 of Remission Induction Treatment Is Predictive for Complete Remission Rate and Survival in Adult Acute Myeloid Leukemia; the Results of Multicenter, Prospective Polish Adult Leukemia Group Trial.

Increasing Efficacy of Autologous Haematopoetic Cell Transplantation in Acute Myeloblastic Leukaemia; a Single Centre Experience in 141 Patients.

Treosulfan-Based Reduced Toxicity Regimen Prior to Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Disorders.

Occurrence and Treatment of Isolated Extramedullary Relapses after Allogeneic Hematopoietic Stem Cell Transplantation for Leukaemias: A Single Institute Experience with 442 Patients.

Improved Survival in Acute Myeloid Leukaemia Patients Aged over 40 Given Cladribine in Combination with Standard Remission Induction (DA 3+7) and Consolidation Treatment (HD AraC). Seven Year Follow-Up of Prospective, Cooperative PALG Study.

High Incidence of Ancestral HLA Haplotype 8.1 and Incomplete DH-JH Immunoglobulin Rearrangement in Persistent Polyclonal B-Cell Lymphocytosis.

Autologous Transplantation of Non-Cryopreserved Bone Marrow for the Treatment of High-Risk Adult Acute Lymphoblastic Leukemia in First Complete Remission.

Independent Prognostic Significance of Cytogenetics, Immunophenotype, Tumor Burden, and Age in Acute Myeloid Leukemia. Analysis of Patients Treated within PALG 1999 Prospective, Randomized Study.

CD52 and CD20 as Potential Targets for Anti-Leukemic Immunotherapy in Adult Acute Lymphoblastic Leukemia.

Lower Relapse Incidence after Non-Cryopreserved Autologous Bone Marrow Transplantation Compared to Peripheral Blood Stem Cell Transplantation for High-Risk Hodgkin’s Lymphoma.

Daunorubicin, Cytarabine and Fludarabine (DAF) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia. Phase II Study by the Polish Adult Leukemia Group (PALG).

Immunophenotyping to Detect Minimal Residual Disease in Adult Acute Lymphoblastic Leukemia - Feasibility and Prognostic Significance.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only